ESPERION THERAPEUTICS INC (ESPR) Stock Analyst Earnings Estimates
NASDAQ:ESPR - Nasdaq - US29664W1053 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 78.4M -65.54% | 75.5M -3.70% | 116.334M 54.08% | 331.26M 184.75% | 351.08M 5.98% | 384.05M 9.39% | 852.36M 121.94% | 547.54M -35.76% | 1.14B 108.20% | 1.367B 19.91% | 473.28M -65.38% | 285.6M -39.66% | |
| EBITDA YoY % growth | -212.79M -76.08% | -179M 15.88% | -155.399M 13.18% | 48.151M 130.99% | -5.232M -110.87% | 40.136M 867.15% | 789.07M 1,865.99% | 38.862M -95.07% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -213.4M -75.78% | -179.5M 15.89% | -155.563M 13.34% | 44.943M 128.89% | 48.218M 7.29% | 36.566M -24.17% | 463.39M 1,167.27% | 168.71M -63.59% | 597.52M 254.17% | 757.45M 26.77% | 179.52M -76.30% | 122.2M -31.93% | |
| Operating Margin | -272.19% | -237.75% | -133.72% | 13.57% | 13.73% | 9.52% | 54.37% | 30.81% | 52.41% | 55.41% | 37.93% | 42.79% | |
| EPS YoY % growth | -9.56 -74.45% | -3.55 62.87% | -2.12 40.28% | -0.32 85.09% | -0.04 86.29% | 0.03 162.75% | 1.89 6,836.63% | 0.47 -75.14% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 69.66% | -0.17 -148.60% | -0.13 60.44% | -0.02 86.40% | 0.38 350.42% | -0.12 25.93% | 0.03 123.44% | 0.05 350.00% | 0.09 -75.84% |
| Revenue Q2Q % growth | 62.817M 94.78% | 51.654M -62.50% | 59.305M -19.68% | 78.202M 51.46% | 170.44M 171.33% | 77.928M 50.87% | 83.742M 41.21% | 90.678M 15.95% | 98.94M -41.95% |
| EBITDA Q2Q % growth | -14.532M 65.57% | -29.152M -140.34% | -22.195M -957.29% | -18.176M -13.67% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.353M 63.76% | -23.559M -132.60% | -17.064M -761.67% | 2.861M 117.85% | 75.123M 589.29% | 13.77M 158.45% | 19.278M 212.97% | 25.908M 805.56% | 33.762M -55.06% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 59.46% | -0.18 | 0.03 | 16.24% |
| Q2 2024 Q2Q % growth | -0.33 28.26% | -0.19 | -0.14 | -75.67% |
| Q1 2024 Q2Q % growth | 0.34 143.04% | 0.05 | 0.29 | 613.01% |
| Q4 2023 Q2Q % growth | -0.50 34.21% | -0.49 | -0.01 | -1.60% |
| Q3 2023 Q2Q % growth | -0.37 54.32% | -0.44 | 0.07 | 16.08% |
| Q2 2023 Q2Q % growth | -0.46 56.19% | -0.62 | 0.16 | 26.23% |
| Q1 2023 Q2Q % growth | -0.79 15.05% | -0.67 | -0.12 | -18.72% |
| Q4 2022 Q2Q % growth | -0.76 57.06% | -0.86 | 0.10 | 11.37% |
| Q3 2022 Q2Q % growth | -0.81 69.08% | -0.94 | 0.13 | 14.09% |
| Q2 2022 Q2Q % growth | -1.05 37.13% | -0.94 | -0.11 | -11.17% |
| Q1 2022 Q2Q % growth | -0.93 73.43% | -1.06 | 0.13 | 12.63% |
| Q4 2021 Q2Q % growth | -1.77 54.50% | -2.32 | 0.55 | 23.55% |
| Q3 2021 Q2Q % growth | -2.62 14.66% | -2.86 | 0.24 | 8.41% |
| Q2 2021 Q2Q % growth | -1.67 -138.66% | -1.88 | 0.21 | 11.15% |
| Q1 2021 Q2Q % growth | -3.50 -23.24% | -2.57 | -0.93 | -36.35% |
| Q4 2020 Q2Q % growth | -3.89 -72.12% | -3.84 | -0.05 | -1.43% |
| Q3 2020 Q2Q % growth | -3.07 -21.83% | -3.50 | 0.43 | 12.41% |
| Q2 2020 Q2Q % growth | 4.32 314.93% | 1.74 | 2.58 | 148.23% |
| Q1 2020 Q2Q % growth | -2.84 -192.51% | -3.36 | 0.52 | 15.51% |
| Q4 2019 Q2Q % growth | -2.26 | -2.72 | 0.46 | 17.00% |
| Q3 2019 Q2Q % growth | -2.52 | -1.99 | -0.53 | -26.73% |
| Q2 2019 Q2Q % growth | -2.01 | -1.90 | -0.11 | -6.05% |
| Q1 2019 Q2Q % growth | 3.07 | 0.75 | 2.32 | 309.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 51.632M 52.00% | 52.348M | -716K | -1.37% |
| Q2 2024 Q2Q % growth | 73.834M 186.33% | 48.443M | 25.391M | 52.41% |
| Q1 2024 Q2Q % growth | 137.735M 466.14% | 85.373M | 52.362M | 61.33% |
| Q4 2023 Q2Q % growth | 32.25M 71.54% | 29.271M | 2.979M | 10.18% |
| Q3 2023 Q2Q % growth | 33.969M 78.78% | 30.175M | 3.794M | 12.57% |
| Q2 2023 Q2Q % growth | 25.786M 37.16% | 25.13M | 656K | 2.61% |
| Q1 2023 Q2Q % growth | 24.329M 29.41% | 22.452M | 1.877M | 8.36% |
| Q4 2022 Q2Q % growth | 18.8M 22.08% | 21.264M | -2.464M | -11.59% |
| Q3 2022 Q2Q % growth | 19M 31.94% | 20.313M | -1.313M | -6.46% |
| Q2 2022 Q2Q % growth | 18.8M -53.81% | 19.083M | -283K | -1.48% |
| Q1 2022 Q2Q % growth | 18.8M 135.00% | 15.695M | 3.105M | 19.78% |
| Q4 2021 Q2Q % growth | 15.4M 60.42% | 14.771M | 629K | 4.26% |
| Q3 2021 Q2Q % growth | 14.4M 278.95% | 12.126M | 2.274M | 18.75% |
| Q2 2021 Q2Q % growth | 40.7M -80.82% | 43.028M | -2.328M | -5.41% |
| Q1 2021 Q2Q % growth | 8M 344.44% | 22.475M | -14.475M | -64.40% |
| Q4 2020 Q2Q % growth | 9.6M 860.00% | 12.766M | -3.166M | -24.80% |
| Q3 2020 Q2Q % growth | 3.8M 280.00% | 5.273M | -1.473M | -27.93% |
| Q2 2020 Q2Q % growth | 212.2M 21,120.00% | 150.93M | 61.27M | 40.59% |
| Q1 2020 Q2Q % growth | 1.8M -98.76% | 528.87K | 1.271M | 240.35% |
| Q4 2019 Q2Q % growth | 1M | 909.636K | 90.364K | 9.93% |
| Q3 2019 Q2Q % growth | 1M | 918K | 82K | 8.93% |
| Q2 2019 Q2Q % growth | 1M | 951.997K | 48.003K | 5.04% |
| Q1 2019 Q2Q % growth | 145.4M | 60.308M | 85.092M | 141.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10.19% | -10.19% | -3.59% | -14.47% |
| Revenue | 0.05% | 0.05% | -0.45% | -4.52% |